BioSpace News Archive

High postural sway doubles older women’s fracture risk

Postural sway is an independent risk factor for bone fractures in postmenopausal women, according to a new study from the University of Eastern Finland and Kuopio University Hospital.

June 19, 2019
·
2 min read
Drug Development

Polyphor announces enrollment of first patient in FORTRESS Phase III clinical trial for balixafortide in combination with eribulin in patients with metastatic breast cancer

Balixafortide is the most advanced and only CXCR4 antagonist in development in a pivotal Oncology global registration trial.

June 19, 2019
·
5 min read
Business

Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases

Scope of the collaboration expands to include up to 12 rare disease targets and includes Arcturus nucleic acid technologies to enable mRNA, DNA, and siRNA therapeutics

June 19, 2019
·
8 min read
CelGro® accelerates dental implant treatments

Regenerative medicine company Orthocell Limited is pleased to announce all patients have successfully completed the CelGro® single-stage dental implant study designed to assess effectiveness and predictability in accelerating treatment timeframes.

June 19, 2019
·
7 min read
Deals

Resolutions Of The Annual General Meeting 2019 Of Evotec SE

Evotec SE announced that its shareholders approved all proposals the Company’s Management put to vote at the Company’s Annual General Meeting 2019 with very strong supporting majorities.

June 19, 2019
·
4 min read
Pharm Country

Audacity Therapeutics Selected to Participate at Upcoming Cavendish BioHealth Impact Forum

Forum uniquely brings together leading family offices, foundations and impact investors seeking impact investment, grant-giving, and philanthropy opportunities within health and the life sciences

June 19, 2019
·
4 min read
Drug Development

Bavarian Nordic Initiates Phase 3 Trial of Freeze-dried MVA-BN® Smallpox Vaccine

Bavarian Nordic A/S announced the initiation of a pivotal Phase 3 trial of the freeze-dried formulation of MVA-BN® smallpox vaccine in 1,110 healthy, vaccinia-naïve subjects.

June 19, 2019
·
4 min read